Latest XDR-TB Stories
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB NEW
Results from an observational study evaluating a new anti-TB drug have found that the treatment can improve outcomes and reduce mortality among patients with both MDR-TB and XDR-TB.
Healthcare workers in South Africa are at a significantly increased risk of developing drug-resistant tuberculosis, or XDR-TB, in a trend which threatens to further exacerbate the already beleaguered healthcare systems in sub-Saharan countries
U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis.
New research on drug-resistant tuberculosis found that the hard-to-treat disease results in death for half of patients who get it.
Aggressive treatment involving a combination of drugs may be the cure for extensively drug-resistant tuberculosis, researchers report.
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB.
Extensively drug-resistant tuberculosis, or XDR-TB, can be commuted in an individualized outpatient therapy program, researchers in Peru said.
- A handkerchief.
- In general, any miraculous portrait of Christ.